Antimicrobial Management of Surgical Necrotizing Enterocolitis: A Multi-Institutional Analysis
In brief
Across 10 hospitals, no antibiotic regimen was linked to better survival
In this retrospective study of 306 infants with surgical necrotizing enterocolitis, teams used 94 initial regimens, and pre- and postoperative regimens differed in 67% of cases. About one in three infants died, but no antibiotic choice or longer postoperative treatment was associated with lower mortality. The findings show wide variation, not which regimen works best; prospective trials are needed.
- Journal
- The Journal of surgical research (Q1)
- Published
- 16 November 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Insiyah Campwala, Utsav M Patwardhan, Gerald Gollin, Toby D Yanowitz, Barbara Gaines, Daniel B Gehle, et al.
- PMID
- 43038844
- DOI
- 10.1016/j.jss.2026.10.043
Why clinicians should know about it
- Picked for Pediatric Surgery (paper of the day, 17 November 2026): Multicentre study addresses antimicrobial practice and outcomes after surgical NEC
Abstract
INTRODUCTION: Evidence-based antimicrobial regimens are lacking for surgical necrotizing enterocolitis. We evaluated the association between antimicrobial practices and outcomes. METHODS: We conducted a retrospective cohort analysis of infants with surgical necrotizing enterocolitis (2010-2019) at ten children's hospitals. Demographics, antimicrobial choice, and postoperative outcomes were assessed using multivariable regression. RESULTS: Among 306 neonates (median gestational age 26 wk [interquartile range 25-29], birth weight 850 g [680-1100], age at diagnosis 8.5 wk [3-21]), 15 antimicrobials were used in 94 initial regimens. Postoperatively, 15 were administered in 107 regimens. Pre- and postoperative regimens differed in 67%. The most frequently used antibiotics were ampicillin, clindamycin, gentamicin, and vancomycin. Antifungals were often given to those with lower weight at diagnosis. 34% died during the index admission. No initial antimicrobial agent was associated with mortality. Excluding early deaths, patients received a median of 14 d of postoperative antibiotics. The duration of postoperative antibiotics (>7 d versus < 7 d) was not significantly associated with in-hospital mortality (odds ratio 0.86, P = 0.93). Adjusted regression analyses demonstrated no associations between postoperative antimicrobial choice and enteral autonomy, stoma complications, neurodevelopmental impairment, or cholestasis. Antifungal use was associated with higher odds of late mortality (odds ratio 5.22, P = 0.023), likely secondary to underlying illness severity. CONCLUSIONS: Antimicrobial management varied widely. No individual antimicrobial agent improved survival; however, binary analysis of antimicrobial exposure limited conclusions. Longer antimicrobial duration was not associated with improved survival. Prospective randomized studies may help define optimal antibiotic management.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.